查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1585605

生物防御市场：按产品、最终用户划分 - 2025-2030 年全球预测

Biodefense Market by Product (Anthrax, Botulism, Radiation), End-User (Ambulatory Care Centers, Hospitals, Military) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年生物防御市场价值为183.6亿美元，预计到2024年将达到203.3亿美元，复合年增长率为11.25%，到2030年将达到387.3亿美元。

生物防御涵盖各种旨在保护人们免受病毒、细菌和其他病原体等生物製剂威胁的策略、研究和技术。这项需求源自于人们对生物武器、生物恐怖主义和自发性爆发的日益担忧，凸显了对强有力的防御机制的迫切需求。 Biodefense 的上市公司应用涵盖公共卫生措施、军事防御战略和医疗基础设施，最终用途包括政府机构、医疗保健提供者、製药公司、研究机构等。生物防御市场的成长主要得益于研发投资的增加、政府和私营部门之间的合作以及增强早期检测和快速反应能力的生物技术的进步。基因组定序、基于人工智慧的预测模型和疫苗开发等技术创新是关键机会，投资改善生物防御基础设施和培训可以进一步增强这些前景。然而，高昂的研发成本、监管障碍以及军民两用研究的伦理问题等挑战构成了重大限制。此外，与生物威胁的不可预测性和复杂的地缘政治局势相关的问题可能会使成长变得复杂。利用潜在机会的策略建议包括促进官民合作关係、增加对用于快速病原体识别的 CRISPR 等新技术的投资，以及资讯共用和资源优化的国际合作。此外，透过合成生物学的进步开发新治疗方法和基本药物的策略储备都是创新的成熟领域。受地缘政治和环境变化影响的市场的动态性质需要不断适应和发展敏捷的回应框架。透过解决这些限制并利用成长机会，相关人员可以确保有弹性和有效的生物防御策略，为全球卫生安全和市场永续性做出重大贡献。生物防御不断发展的性质要求采取积极主动的方法，结合最尖端科技并促进全球协调应对生物威胁。

主要市场统计
基准年[2023] 183.6亿美元
预测年份 [2024] 203.3亿美元
预测年份 [2030] 387.3亿美元
复合年增长率（%） 11.25%

市场动态：揭示快速发展的生物防御市场的关键市场洞察

生物防御市场正因​​供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 存在有利的政府倡议
    • 伊波拉病毒和齐瓦病毒等各种病原体的盛行率不断上升
    • 疾病监测的重要性日益增加
  • 市场限制因素
    • 开发中国家和低度开发国家的市场渗透率低
  • 市场机会
    • 已开发国家不断增加的倡议
    • 生物技术的技术进步
  • 市场挑战
    • 高时间投入和长临床程序

波特五力：驾驭生物防御市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物防御市场的外部影响

外部宏观环境因素在塑造生物防御市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物防御市场的竞争格局

对生物防御市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物防御市场供应商的绩效评估

FPNV定位矩阵是评估生物防御市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了生物防御市场的成功之路

生物防御市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 存在有利的政府倡议
      • 伊波拉病毒、齐瓦病毒等多种病原体的传播正在加剧。
      • 疾病监测的重要性日益增加
    • 抑制因素
      • 开发中国家和最不开发中国家的市场渗透率较低
    • 机会
      • 已开发国家加强研发力度
      • 生物技术的技术进步
    • 任务
      • 大量的时间投入和漫长的临床程序
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物防御市场：副产品

  • 炭疽菌
  • 肉毒中毒
  • 辐射
  • 天花

第七章生物防御市场：依最终用户分类

  • 门诊治疗中心
  • 医院
  • 军队
  • 调查机构

第八章美洲生物防御市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太生物防御市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的生物防御市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alnylam Pharmaceuticals, Inc.
  • Altimmune, Inc.
  • Bavarian Nordic A/S
  • BDO USA, LLP
  • Bharat Biotech Ltd.
  • Dynport Vaccine Company by General Dynamics Information Technology
  • Elusys Therapeutics, Inc. by Heat Biologics Inc.
  • Emergent BioSolutions Inc.
  • Evogen, Inc.
  • Ichor Medical Systems, Inc.
  • Pizer Inc.
  • Serum Institute of India Pvt. Ltd.
  • SIGA Technologies
  • Soligenix, Inc.
  • Xoma Corporation
Product Code: MRR-434CCDA050CE

The Biodefense Market was valued at USD 18.36 billion in 2023, expected to reach USD 20.33 billion in 2024, and is projected to grow at a CAGR of 11.25%, to USD 38.73 billion by 2030.

Biodefense encompasses a range of strategies, research, and technologies aimed at protecting populations against threats from biological agents like viruses, bacteria, and other pathogens. Its necessity arises from growing concerns over biological warfare, bioterrorism, and naturally occurring outbreaks, underscoring the critical need for robust defense mechanisms. Applications of biodefense extend to public health preparedness, military defense strategies, and healthcare infrastructure, while its end-use scope includes government agencies, healthcare providers, pharmaceutical companies, and research institutions. Market growth in biodefense is primarily driven by increasing investment in R&D, collaborative efforts between government and private sectors, and advancements in biotechnology which enhance early detection and rapid response capabilities. Technological innovations such as genomic sequencing, AI-based predictive modeling, and vaccine development represent key opportunities, while investment in improving biodefense infrastructure and training can further enhance these prospects. However, challenges such as high R&D costs, regulatory hurdles, and ethical concerns over dual-use research pose significant limitations. Furthermore, issues related to the unpredictability of biological threats and the complex geopolitical landscape can complicate growth. Strategic recommendations to leverage potential opportunities include fostering public-private partnerships, increasing investment in emerging technologies like CRISPR for rapid pathogen identification, and enhancing international collaboration for information sharing and resource optimization. Exploring advancements in synthetic biology for developing novel countermeasures and strategic stockpiling of essential medical supplies are areas ripe for innovation. The market's dynamic nature, affected by geopolitical and environmental shifts, necessitates continuous adaptation and development of agile response frameworks. By addressing these limitations and capitalizing on growth opportunities, stakeholders can ensure resilient and effective biodefense strategies, making substantial contributions to global health security and market sustainability. The evolving nature of biodefense calls for a proactive approach in embracing cutting-edge technology and fostering a globally coordinated response to biological threats.

KEY MARKET STATISTICS
Base Year [2023] USD 18.36 billion
Estimated Year [2024] USD 20.33 billion
Forecast Year [2030] USD 38.73 billion
CAGR (%) 11.25%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biodefense Market

The Biodefense Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Presence of favorable government initiatives
    • Growing prevalence of various agents such as Ebola virus, Ziva virus, and others
    • Increasing importance of disease surveillance
  • Market Restraints
    • Low market penetration in developing and underdeveloped countries
  • Market Opportunities
    • Rising initiatives for research & developments in developed countries
    • Technological advancement in biotechnology
  • Market Challenges
    • High time investment and longer clinical procedures

Porter's Five Forces: A Strategic Tool for Navigating the Biodefense Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biodefense Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biodefense Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biodefense Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biodefense Market

A detailed market share analysis in the Biodefense Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biodefense Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biodefense Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biodefense Market

A strategic analysis of the Biodefense Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biodefense Market, highlighting leading vendors and their innovative profiles. These include Alnylam Pharmaceuticals, Inc., Altimmune, Inc., Bavarian Nordic A/S, BDO USA, LLP, Bharat Biotech Ltd., Dynport Vaccine Company by General Dynamics Information Technology, Elusys Therapeutics, Inc. by Heat Biologics Inc., Emergent BioSolutions Inc., Evogen, Inc., Ichor Medical Systems, Inc., Pizer Inc., Serum Institute of India Pvt. Ltd., SIGA Technologies, Soligenix, Inc., and Xoma Corporation.

Market Segmentation & Coverage

This research report categorizes the Biodefense Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Anthrax, Botulism, Radiation, and Small Pox.
  • Based on End-User, market is studied across Ambulatory Care Centers, Hospitals, Military, and Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Presence of favorable government initiatives
      • 5.1.1.2. Growing prevalence of various agents such as Ebola virus, Ziva virus, and others
      • 5.1.1.3. Increasing importance of disease surveillance
    • 5.1.2. Restraints
      • 5.1.2.1. Low market penetration in developing and underdeveloped countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising initiatives for research & developments in developed countries
      • 5.1.3.2. Technological advancement in biotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. High time investment and longer clinical procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biodefense Market, by Product

  • 6.1. Introduction
  • 6.2. Anthrax
  • 6.3. Botulism
  • 6.4. Radiation
  • 6.5. Small Pox

7. Biodefense Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Care Centers
  • 7.3. Hospitals
  • 7.4. Military
  • 7.5. Research Organizations

8. Americas Biodefense Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biodefense Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biodefense Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alnylam Pharmaceuticals, Inc.
  • 2. Altimmune, Inc.
  • 3. Bavarian Nordic A/S
  • 4. BDO USA, LLP
  • 5. Bharat Biotech Ltd.
  • 6. Dynport Vaccine Company by General Dynamics Information Technology
  • 7. Elusys Therapeutics, Inc. by Heat Biologics Inc.
  • 8. Emergent BioSolutions Inc.
  • 9. Evogen, Inc.
  • 10. Ichor Medical Systems, Inc.
  • 11. Pizer Inc.
  • 12. Serum Institute of India Pvt. Ltd.
  • 13. SIGA Technologies
  • 14. Soligenix, Inc.
  • 15. Xoma Corporation

LIST OF FIGURES

  • FIGURE 1. BIODEFENSE MARKET RESEARCH PROCESS
  • FIGURE 2. BIODEFENSE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIODEFENSE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIODEFENSE MARKET DYNAMICS
  • TABLE 7. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIODEFENSE MARKET SIZE, BY RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIODEFENSE MARKET SIZE, BY SMALL POX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIODEFENSE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIODEFENSE MARKET SIZE, BY MILITARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIODEFENSE MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2023